On July 11, Arrowhead Research Corporation fell 7.92% in regular trading, trading at $77.45 USD/share, with Turnover of $98.63 million.
Within the Biotechnology sector where Arrowhead Research Corporation belongs, the overall sector performance was weak. Among individual stocks, AbbVie down 1.32%, Ionis Pharmaceuticals down 8.46%, Moderna down 10.42%, Gilead Sciences down 3.26%, Alnylam Pharmaceuticals down 4.37%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)